{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:40:06Z","timestamp":1785591606847,"version":"3.56.0"},"reference-count":64,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health"},{"name":"\u201cFondazione Veronesi\u201d 2021 fellowship program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: We evaluated the efficacy of a good lifestyle intervention on the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children with Down syndrome (DS). Methods: This retrospective longitudinal study included 31 children with Down syndrome (DS) who were affected by MASLD and attended nutritional counseling based on a nutritional approach (e.g., Mediterranean diet and antioxidant supplements), as well as physical exercise. Clinical parameters, markers of low-grade systemic inflammation, and hepatic steatosis, as assessed by ultrasound, were evaluated at baseline (T0) and after 6 months (T1). Results: Several anthropometric and biochemical parameters, including body mass index, waist circumference, diastolic and systolic blood pressure, aspartate aminotransferase, basal insulin, insulin resistance, pro-inflammatory interleukin-1\u03b2, and anti-inflammatory interleukin-10, showed significant improvement after 6 months of a nutritional approach. This study also found a regression of at least one grade of hepatic steatosis in a significant portion of patients, especially in those who received antioxidant supplements. Conclusions: Our study further supports the hypothesis that a healthy lifestyle intervention, based on adherence to the Mediterranean diet, natural supplements with antioxidant properties, and regular physical activity, can be considered a safe therapeutic approach for reducing the risk and severity of MASLD in children with DS.<\/jats:p>","DOI":"10.3390\/nu17142331","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T10:46:05Z","timestamp":1752662765000},"page":"2331","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lifestyle Intervention Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Down Syndrome"],"prefix":"10.3390","volume":"17","author":[{"given":"Vittorio","family":"Scoppola","sequence":"first","affiliation":[{"name":"Research Unit of Genetics of Complex Phenotypes, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Crudele","sequence":"additional","affiliation":[{"name":"Research Unit of Genetics of Complex Phenotypes, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9646-7462","authenticated-orcid":false,"given":"Antonella","family":"Mosca","sequence":"additional","affiliation":[{"name":"Hepatology and Liver Transplant Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Panera","sequence":"additional","affiliation":[{"name":"Research Unit of Genetics of Complex Phenotypes, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara di","family":"Camillo","sequence":"additional","affiliation":[{"name":"General Pediatrics and ED II Level Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Bock","sequence":"additional","affiliation":[{"name":"Diagnostic and Interventional Radiology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Raponi","sequence":"additional","affiliation":[{"name":"Medical Direction, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-0424","authenticated-orcid":false,"given":"Alberto","family":"Villani","sequence":"additional","affiliation":[{"name":"General Pediatrics and ED II Level Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7241-6329","authenticated-orcid":false,"given":"Anna","family":"Alisi","sequence":"additional","affiliation":[{"name":"Research Unit of Genetics of Complex Phenotypes, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0378-4499","authenticated-orcid":false,"given":"Diletta","family":"Valentini","sequence":"additional","affiliation":[{"name":"General Pediatric Folllow-Up Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Chen, L., Wang, L., Wang, Y., Hu, H., Zhan, Y., Zeng, Z., and Liu, L. (2022). Global, Regional, and National Burden and Trends of Down Syndrome From 1990 to 2019. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.908482"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down Syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajmg.a.38512","article-title":"Co-occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines","volume":"176","author":"Capone","year":"2018","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ridd.2016.06.018","article-title":"Overweight and obesity in children and adolescents with Down syndrome-prevalence, determinants, consequences, and interventions: A literature review","volume":"57","author":"Bertapelli","year":"2016","journal-title":"Res. Dev. Disabil."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejmg.2016.06.005","article-title":"Lipid profiles in a large cohort of Italian children with Down syndrome","volume":"59","author":"Buonuomo","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e20190137","DOI":"10.1542\/peds.2019-0137","article-title":"Cardiometabolic Risk and Body Composition in Youth With Down Syndrome","volume":"144","author":"Magge","year":"2019","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.2337\/dc22-0482","article-title":"Diabetes and Obesity in Down Syndrome Across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health Records","volume":"45","author":"Aslam","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1097\/HEP.0000000000000695","article-title":"Letter to the Editor: A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Hoofnagle","year":"2024","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpeds.2017.05.077","article-title":"Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features","volume":"189","author":"Valentini","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.numecd.2020.05.012","article-title":"PNPLA3 gene polymorphism is associated with liver steatosis in children with Down syndrome","volume":"30","author":"Valentini","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Karjoo, S., Braglia-Tarpey, A., Chan, A.P., Ayala Germ\u00e1n, A.G., Herdes, R.E., Pai, N., Sierra-Velez, D., Whitehead, B., Quiros-Tejeira, R.E., and Duro, D. (2025). Evidence-based review of the nutritional treatment of obesity and metabolic dysfunction-associated steatotic liver disease in children and adolescents. J. Pediatr. Gastroenterol. Nutr., Epub ahead of print.","DOI":"10.1002\/jpn3.70099"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): An update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Spiezia, C., Di Rosa, C., Fintini, D., Ferrara, P., De Gara, L., and Khazrai, Y.M. (2023). Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis. Nutrients, 15.","DOI":"10.3390\/nu15112435"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Riolo, R., De Rosa, R., Simonetta, I., and Tuttolomondo, A. (2022). Olive Oil in the Mediterranean Diet and Its Biochemical and Molecular Effects on Cardiovascular Health through an Analysis of Genetics and Epigenetics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416002"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.3390\/nu7115459","article-title":"Definition of the Mediterranean Diet: A Literature Review","volume":"7","author":"Davis","year":"2015","journal-title":"Nutrients"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e12872","DOI":"10.1111\/ijpo.12872","article-title":"The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial","volume":"17","author":"Akbulut","year":"2022","journal-title":"Pediatr. Obes."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/chi.2015.0197","article-title":"Association between Adherence to the Mediterranean Diet and Presence of Nonalcoholic Fatty Liver Disease in Children","volume":"12","author":"Cakir","year":"2016","journal-title":"Child. Obes."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2018.05.002","article-title":"A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease","volume":"58","author":"Panera","year":"2018","journal-title":"Nutr. Res."},{"key":"ref_19","first-page":"8","article-title":"Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study","volume":"39\u201340","author":"Mosca","year":"2017","journal-title":"Nutrition"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.clnu.2023.03.021","article-title":"Practical guideline on obesity care in patients with gastrointestinal and liver diseases\u2014Joint ESPEN\/UEG guideline","volume":"42","author":"Bischoff","year":"2023","journal-title":"Clin. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wang, L.L., Zhang, P.H., and Yan, H.H. (2023). Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1014010"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Association for the Study of the Liver (EASL), North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), Latin-American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (LASPGHAN), Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition (APPSPGHAN), Pan Arab Society for Pediatric Gastroenterology and Nutrition (PASPGHAN), Commonwealth Association of Paediatric Gastroenterology & Nutrition (CAPGAN), and Federation of International Societies of Pediatric Hepatology, Gastroenterology and Nutrition (FISPGHAN) (2023). Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature. J. Pediatr. Gastroenterol. Nutr., 78, 1190\u20131196.","DOI":"10.1002\/jpn3.12156"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/PEP.0000000000000556","article-title":"Physical Activity Levels of Children with Down Syndrome","volume":"31","author":"Fox","year":"2019","journal-title":"Pediatr. Phys. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rossi, L., Behme, N., and Breuer, C. (2021). Physical Activity of Children and Adolescents During the COVID-19 Pandemic\u2014A Scoping Review. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182111440"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1542\/peds.2011-1605","article-title":"Health supervision for children with Down syndrome","volume":"128","author":"Bull","year":"2011","journal-title":"Pediatrics"},{"key":"ref_26","first-page":"921","article-title":"Associations between homeostasis model assessment (HOMA) and routinely examined parameters in individuals with metabolic syndrome","volume":"68","year":"2019","journal-title":"Physiol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","article-title":"Diagnosis of nonalcoholic fatty liver disease in children and adolescents: Position paper of the ESPGHAN Hepatology Committee","volume":"54","author":"Vajro","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1079\/PHN2004556","article-title":"Food, youth and the Mediterranean diet in Spain. Development of KIDMED, Mediterranean Diet Quality Index in Children and Adolescents","volume":"7","author":"Ribas","year":"2004","journal-title":"Public Health Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1479-5868-8-115","article-title":"Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review","volume":"8","author":"Lee","year":"2011","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lonardo, A., Ballestri, S., Mantovani, A., Targher, G., and Bril, F. (2024). Endpoints in NASH Clinical Trials: Are We Blind in One Eye?. Metabolites, 14.","DOI":"10.3390\/metabo14010040"},{"key":"ref_32","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2024). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol., 81, 492\u2013542."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e0583","DOI":"10.1097\/HC9.0000000000000583","article-title":"A healthy lifestyle is prospectively associated with lower onset of metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Grinshpan","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4597246","DOI":"10.1155\/2016\/4597246","article-title":"Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease","volume":"2016","author":"Oliveira","year":"2016","journal-title":"J Diabetes Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jamainternmed.2024.6431","article-title":"A Clinical Update on MASLD","volume":"185","author":"Zhang","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Xanthakos, S.A., Ibrahim, S.H., Adams, K., Kohli, R., Sathya, P., Sundaram, S., Vos, M.B., Dhawan, A., Caprio, S., and Behling, C.A. (2025). AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children. Hepatology, early view.","DOI":"10.1097\/HEP.0000000000001368"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/dc19-0351","article-title":"Effects of exercise in addition to a family-based lifestyle intervention program on hepatic fat in children with overweight","volume":"43","author":"Labayen","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00125-017-4264-9","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: Do they lead to over-referral?","volume":"60","author":"Blond","year":"2017","journal-title":"Diabetologia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/jmf.2011.0075","article-title":"The effect of the Spanish Ketogenic Mediterranean Diet on non-alcoholic fatty liver disease: A pilot study","volume":"14","year":"2011","journal-title":"J. Med. Food"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Plaz Torres, M.C., Aghemo, A., Lleo, A., Bodini, G., Furnari, M., Marabotto, E., Miele, L., and Giannini, E.G. (2019). Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered. Nutrients, 11.","DOI":"10.3390\/nu11122971"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Montemayor, S., Garc\u00eda, S., Monserrat-Mesquida, M., Tur, J.A., and Bouzas, C. (2023). Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review. Nutrients, 15.","DOI":"10.3390\/nu15183987"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Gambardella, M.L., Scarlata, G.G.M., Lenci, I., Baiocchi, L., and Luzza, F. (2024). The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation. Medicina, 60.","DOI":"10.20944\/preprints202403.0587.v1"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mascar\u00f3, C.M., Bouzas, C., and Tur, J.A. (2022). Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review. Nutrients, 14.","DOI":"10.3390\/nu14010049"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/17474124.2017.1291340","article-title":"Clinical implications of understanding the association between oxidative stress and pediatric NAFLD","volume":"11","author":"Mann","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-024-03889-x","article-title":"Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: A review","volume":"99","year":"2025","journal-title":"Arch. Toxicol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pediatric16020025","article-title":"Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?","volume":"16","author":"Antonella","year":"2024","journal-title":"Pediatr. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1139\/apnm-2016-0689","article-title":"Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: A randomised controlled clinical trial","volume":"42","author":"Alisi","year":"2017","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/ars.2018.7704","article-title":"The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?","volume":"31","author":"Nobili","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.dld.2020.09.021","article-title":"Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD","volume":"53","author":"Mosca","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Panera, N., Braghini, M.R., Crudele, A., Smeriglio, A., Bianchi, M., Condorelli, A.G., Nobili, R., Conti, L.A., De Stefanis, C., and Lioci, G. (2022). Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis. Nutrients, 14.","DOI":"10.3390\/nu14183791"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Fytili, C., Nikou, T., Tentolouris, N., Tseti, I.K., Dimosthenopoulos, C., Sfikakis, P.P., Simos, D., Kokkinos, A., Skaltsounis, A.L., and Katsilambros, N. (2022). Effect of Long-Term Hydroxytyrosol Administration on Body Weight, Fat Mass and Urine Metabolomics: A Randomized Double-Blind Prospective Human Study. Nutrients, 14.","DOI":"10.3390\/nu14071525"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neubiorev.2016.10.023","article-title":"Plant polyphenols as natural drugs for the management of Down syndrome and related disorders","volume":"71","author":"Vacca","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ridd.2014.03.013","article-title":"Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome","volume":"35","author":"Parisotto","year":"2014","journal-title":"Res. Dev. Disabil."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in down syndrome: Molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Rueda Revilla, N., and Mart\u00ednez-Cu\u00e9, C. (2020). Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials. Antioxidants, 9.","DOI":"10.3390\/antiox9080692"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Park, J.S., Rustamov, N., and Roh, Y.S. (2023). The Roles of NFR2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases. Antioxidants, 12.","DOI":"10.3390\/antiox12111928"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1039\/C7FO00090A","article-title":"Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-\u03b1 and Nrf2 activation, and NF-\u03baB down-regulation","volume":"8","author":"Valenzuela","year":"2017","journal-title":"Food Funct."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1007\/s10620-019-05657-9","article-title":"Vitamin E Ameliorates Lipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease via Nrf2\/CES1 Signaling Pathway","volume":"64","author":"He","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4102\/ajod.v8i0.576","article-title":"The health benefits of exercise therapy for patients with Down syndrome: A systematic review","volume":"8","author":"Paul","year":"2019","journal-title":"Afr. J. Disabil."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Wu, Q., Luo, Y., Lu, H., Xie, T., Hu, Z., Chu, Z., and Luo, F. (2024). The Potential Role of Vitamin E and the Mechanism in the Prevention and Treatment of Inflammatory Bowel Disease. Foods, 13.","DOI":"10.3390\/foods13060898"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Tang, J., Zhang, M., Wang, J., Zhang, H., Wang, Z., Lei, Z., Wang, C., and Chen, W. (2025). Hydroxytyrosol Ameliorates Colon Inflammation: Mechanistic Insights into Anti-Inflammatory Effects, Inhibition of the TLR4\/NF-\u03baB Signaling Pathway, Gut Microbiota Modulation, and Liver Protection. Foods, 14.","DOI":"10.3390\/foods14071270"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s12072-024-10674-6","article-title":"Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: Clinical impact","volume":"18","author":"Alisi","year":"2024","journal-title":"Hepatol. Int."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/14\/2331\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:10:33Z","timestamp":1760033433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/14\/2331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":64,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["nu17142331"],"URL":"https:\/\/doi.org\/10.3390\/nu17142331","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}